Next Article in Journal
Potentiation of Recombinant NP and M1-Induced Cellular Immune Responses and Protection by Physical Radiofrequency Adjuvant
Next Article in Special Issue
Financing of Immunization Programs by Local Government Units in Poland as an Element of Health Policy
Previous Article in Journal
PICK-ing Malaysia’s Epidemic Apart: Effectiveness of a Diverse COVID-19 Vaccine Portfolio
Previous Article in Special Issue
Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis
 
 
Article

Article Versions Notes

Vaccines 2021, 9(12), 1380; https://doi.org/10.3390/vaccines9121380
Action Date Notes Link
article xml file uploaded 24 November 2021 10:28 CET Original file -
article xml uploaded. 24 November 2021 10:28 CET Update https://www.mdpi.com/2076-393X/9/12/1380/xml
article pdf uploaded. 24 November 2021 10:28 CET Version of Record https://www.mdpi.com/2076-393X/9/12/1380/pdf
article supplementary file uploaded. 24 November 2021 10:28 CET - https://www.mdpi.com/2076-393X/9/12/1380#supplementary
article html file updated 24 November 2021 10:29 CET Original file -
article html file updated 30 July 2022 18:25 CEST Update https://www.mdpi.com/2076-393X/9/12/1380/html
Back to TopTop